# Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.

> **NCT07564245** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 21 (estimated)

## Conditions studied

- Neurodevelopmental Disorders With Severe Self-injuries

## Interventions

- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT07564245
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-05
- **Final completion:** 2030-02
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07564245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07564245, "Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07564245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*